A bifunctional antibody, the technology at the basis of which was originally designed with the BioExcel HADDOCK software, is now a FDA-approved cancer therapeutic GalleryA bifunctional antibody, the technology at the basis of which was originally designed with the BioExcel HADDOCK software, is now a FDA-approved cancer therapeutic
A bifunctional antibody, the technology at the basis of which was originally designed with the BioExcel HADDOCK software, is now a FDA-approved cancer therapeutic
by Alexandre Bonvin, Utrecht University Merus, a biotech company based [...]
Webinar: Modelling antibodies in the post-Alphafold era: where are we now? (2025-4-8)
Date: 8 April 2025 Time: 15:00 CET Registration [...]
Webinar: Cryo-EM structure refinement with density-guided simulations in GROMACS (2025-3-4)
View slides on Zenodo Access our [...]
Webinar: What’s new in GROMACS 2025 (2025-2-18)
View slides on Zenodo Access our forum [...]
